Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Depreciation & Amortization (CF) (2016 - 2025)

Assembly Biosciences has reported Depreciation & Amortization (CF) over the past 11 years, most recently at $32000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $32000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $129000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $129000.0, changed 0.0%.
  • Depreciation & Amortization (CF) for Q4 2025 was $32000.0 at Assembly Biosciences, roughly flat from $32000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for ASMB hit a ceiling of $134000.0 in Q3 2022 and a floor of $32000.0 in Q1 2024.
  • Median Depreciation & Amortization (CF) over the past 5 years was $111500.0 (2021), compared with a mean of $83600.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): grew 12.61% in 2022 and later plummeted 74.6% in 2024.
  • Assembly Biosciences' Depreciation & Amortization (CF) stood at $120000.0 in 2021, then grew by 3.33% to $124000.0 in 2022, then plummeted by 32.26% to $84000.0 in 2023, then plummeted by 61.9% to $32000.0 in 2024, then changed by 0.0% to $32000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $32000.0 (Q4 2025), $32000.0 (Q3 2025), and $32000.0 (Q2 2025) per Business Quant data.